Aganepag - CAS 910562-18-4

Aganepag, a potent Prostanoid EP2 receptor agonist, exhibits remarkable selectivity with an EC50 of 0.19 nM, demonstrating no activity at the EP4 receptor. Its applications are primarily in the fields of wound healing, scar reduction, scar prevention, and the treatment and prevention of wrinkles.

Prostaglandin Receptor

Immunology/Inflammation, GPCR/G Protein

910540

C24H31NO4S

429.57

CCCCC[C@H](O)c1ccc(cc1)N1[C@@H](CCCc2ccc(s2)C(O)=O)CCC1=O

-20°C

Ice Packs

Small Compound